Pharmaceutical products package and health

This procedure concerns a package of measures related to pharmaceutical products and their impact on public health. It aims to ensure the availability, accessibility, and affordability of medicines across the EU.

The measures will affect pharmaceutical companies, healthcare providers, and ultimately patients. Key changes may include updated regulations on drug approval, pricing, and supply chain management.